Victor Neduva is an experienced leader in the field of computational biology and drug discovery, currently serving as the Head of Target Discovery & Disease Data at Roche's Pharma Research and Early Development (pRED) division. Victor holds an honorary lecturership at Imperial College London and has previously held significant roles including Senior Director at MSD in the UK and Group Leader at GlaxoSmithKline. Victor's academic credentials include a PhD in Computational and Systems Biology from the European Molecular Biology Laboratory and Heidelberg University, complemented by a brief executive education experience at Cambridge Judge Business School.